找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Antidepressants; New Pharmacological Phil Skolnick Book 1997 Springer Science+Business Media New York 1997 calcium.lead.mood disorder.rese

[復(fù)制鏈接]
樓主: 推翻
11#
發(fā)表于 2025-3-23 09:54:37 | 只看該作者
12#
發(fā)表于 2025-3-23 16:30:46 | 只看該作者
13#
發(fā)表于 2025-3-23 19:54:08 | 只看該作者
14#
發(fā)表于 2025-3-23 22:50:36 | 只看該作者
15#
發(fā)表于 2025-3-24 02:23:35 | 只看該作者
16#
發(fā)表于 2025-3-24 09:14:55 | 只看該作者
A Role for CREB in Antidepressant Action,ntracellular cascades control virtually every aspect of neuronal function, including the regulation of gene transcription. It is reasonable to hypothesize that adaptations of these intracellular sites are responsible for the therapeutic action of antidepressant treatments .–..
17#
發(fā)表于 2025-3-24 13:39:41 | 只看該作者
Strategies to Optimize the Antidepressant Action of Selective Serotonin Reuptake Inhibitors,any brain neuronal systems, the serotonin (5-hydroxytryptamine, 5-HT) system is the most common neurobiological target for such treatments. Tricyclic antidepressants (TCAs) act on 5-HT and noradrenergic (NE) neurons by inhibiting, with different potencies, transmitter reuptake ., and monoamine (MAO)
18#
發(fā)表于 2025-3-24 14:55:13 | 只看該作者
,Antidepressant Properties of Specific Serotonin—Noradrenaline Reuptake Inhibitors,antidepressant starts to produce its therapeutic effect in less than 2–3 wk. Although considerable progress has been made in improving the tolerability of antidepressant drugs, the tricyclic antidepressants (TCAs), developed in the early 1960s, are still the “gold standard” for antidepressant effica
19#
發(fā)表于 2025-3-24 19:22:59 | 只看該作者
20#
發(fā)表于 2025-3-25 02:01:03 | 只看該作者
Reversible Inhibitors of Monoamine Oxidase A (RIMAs),hese are considerably safer than the older, nonselective irreversible monoamine oxidase inhibitors (MAOIs), in that they have much less interaction with tyramine and certain drugs. Many trials have shown them to be of benefit in depression, and there is room for more variants of this type of drug to
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-11 00:41
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
东至县| 夹江县| 名山县| 海淀区| 东乌珠穆沁旗| 太湖县| 辉县市| 京山县| 凌海市| 新河县| 班玛县| 玉溪市| 南陵县| 玉山县| 江都市| 苗栗县| 金乡县| 北宁市| 福建省| 剑川县| 宣化县| 突泉县| 成都市| 富民县| 南和县| 繁峙县| 淅川县| 股票| 寻乌县| 红原县| 灵宝市| 鱼台县| 郑州市| 建宁县| 凌源市| 镇江市| 林芝县| 昂仁县| 上林县| 江西省| 绩溪县|